OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 1,449,275 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa acquired 1,449,275 shares of the firm’s stock in a transaction dated Thursday, July 30th. The shares were purchased at an average cost of $0.69 per share, with a total value of $999,999.75. Following the completion of the transaction, the director owned 18,538,150 shares in the company, valued at approximately $12,791,323.50. The trade was a 8.48% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Thomas Kosasa also recently made the following trade(s):

• On Friday, June 12th, Thomas Kosasa bought 158,730 shares of OneMedNet stock. The shares were purchased at an average price of $0.63 per share, with a total value of $99,999.90.
• On Monday, May 18th, Thomas Kosasa bought 268,817 shares of OneMedNet stock. The shares were purchased at an average price of $0.93 per share, with a total value of $249,999.81.

OneMedNet Price Performance

NASDAQ:ONMD opened at $0.62 on Friday. The firm has a market capitalization of $35.57 million, a PE ratio of -12.49 and a beta of 1.14. The business’s fifty day moving average price is $0.67 and its 200 day moving average price is $0.78. OneMedNet Corporation has a 12 month low of $0.44 and a 12 month high of $4.22.

OneMedNet (NASDAQ:ONMD) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $0.10 million during the quarter.

Analysts Set New Price Targets

ONMD has been the topic of several research analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen downgraded OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, OneMedNet currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On OneMedNet

A number of institutional investors and hedge funds have recently bought and sold shares of ONMD. HRT Financial LP acquired a new position in OneMedNet in the fourth quarter valued at $32,000. Virtu Financial LLC acquired a new stake in shares of OneMedNet during the fourth quarter worth about $48,000. Jane Street Group LLC purchased a new stake in shares of OneMedNet in the 4th quarter valued at about $119,000. State Street Corp lifted its holdings in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC boosted its position in shares of OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares during the period. 0.95% of the stock is owned by hedge funds and other institutional investors.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.